Method for Establishing a Circuit Switched Call at a Dual Mode Access Terminal
    21.
    发明申请
    Method for Establishing a Circuit Switched Call at a Dual Mode Access Terminal 审中-公开
    在双模接入终端建立电路交换呼叫的方法

    公开(公告)号:US20100067456A1

    公开(公告)日:2010-03-18

    申请号:US12375439

    申请日:2007-07-09

    IPC分类号: H04W88/06 H04L12/66

    CPC分类号: H04W36/0022 H04W88/06

    摘要: A method for establishing a circuit switched call at an access terminal that is processing an established packet switched call, enables a user to be informed that a voice call has been requested. The method comprises transmitting, from a visited network to the access terminal, a packet switched message indicating that the voice call has been requested (step 805). A message from the access terminal, indicating that the voice call is being processed, is then processed in the visited network (step 810). A message from the access terminal requesting a circuit switched call origination is then processed at a mobile switching center in the visited network (step 820). A message indicating that the circuit switched call should be established is then transmitted from the visited network to a voice call continuity application server in a home network, in response to the circuit switched call origination message (step 830). The circuit switched call is then connected (step 835).

    摘要翻译: 一种用于在正在处理建立的分组交换呼叫的接入终端建立电路交换呼叫的方法,使得用户能够被通知语音呼叫已被请求。 该方法包括从访问网络向接入终端发送指示已经请求语音呼叫的分组交换消息(步骤805)。 然后在访问网络中处理来自接入终端的指示正在处理语音呼叫的消息(步骤810)。 然后在访问网络中的移动交换中心处处理来自请求电路交换呼叫发起的接入终端的消息(步骤820)。 响应于电路交换呼叫发起消息,指示应该建立电路交换呼叫的消息然后从归属网络中的受访网络发送到家庭网络中的语音呼叫连续性应用服务器(步骤830)。 然后连接电路交换呼叫(步骤835)。

    METHOD AND SYSTEM FOR ENABLING A CONFERENCE CALL
    22.
    发明申请
    METHOD AND SYSTEM FOR ENABLING A CONFERENCE CALL 审中-公开
    用于启用会议呼叫的方法和系统

    公开(公告)号:US20090325561A1

    公开(公告)日:2009-12-31

    申请号:US12302606

    申请日:2007-05-10

    申请人: Chuan Xu Xiang Xu

    发明人: Chuan Xu Xiang Xu

    IPC分类号: H04M3/56 H04B7/00

    摘要: A method and system enables a conference call that includes a push-to-talk over cellular (PoC) call session and a non-PoC over cellular call session. The method includes establishing a PoC call session between a first communication device and a second communication device using a PoC server (step 705). A non-PoC call session is also established between the first communication device and a third communication device (step 710). Transcoded media data are then generated by transcoding and buffering media data received at the first communication device from the third communication device (step 715). Permission to transmit in the PoC call session is then received at the first communication device from the PoC server (step 725). The transcoded media data are then transmitted, from the first communication device to the push-to-talk over cellular server, for forwarding to the second communication device (step 730).

    摘要翻译: 一种方法和系统使得能够进行电话会议,该会议呼叫包括蜂窝(PoC)呼叫会话和非PoC蜂窝呼叫会话。 该方法包括使用PoC服务器在第一通信设备和第二通信设备之间建立PoC呼叫会话(步骤705)。 也在第一通信设备和第三通信设备之间建立非PoC呼叫会话(步骤710)。 然后通过对来自第三通信设备的第一通信设备接收的媒体数据进行代码转换和缓冲来产生经转码的媒体数据(步骤715)。 然后在PoC呼叫会话中发送的权限在第一通信设备处从PoC服务器接收(步骤725)。 然后,经转码的媒体数据从第一通信设备传送到蜂窝式通话服务器上的一键通,用于转发到第二通信设备(步骤730)。

    IAPs associated cell cycle proteins, compositions and methods of use
    23.
    发明授权
    IAPs associated cell cycle proteins, compositions and methods of use 失效
    IAPs相关细胞周期蛋白,组合物和使用方法

    公开(公告)号:US07420045B1

    公开(公告)日:2008-09-02

    申请号:US10130555

    申请日:2000-11-17

    CPC分类号: C07K14/4747 A61K38/00

    摘要: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also, provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.

    摘要翻译: 本发明涉及对细胞周期有影响或与细胞周期有关的新型多肽,核酸和相关分子。 此外,本文提供的是包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及用于产生本发明多肽的方法 本发明。 本发明还提供了鉴定介导细胞周期生物活性的新型组合物的方法,以及这些组合物在疾病诊断和治疗中的应用。

    INTER-PACKET-NODE PAGING BETWEEN COMMUNICATION NETWORKS
    24.
    发明申请
    INTER-PACKET-NODE PAGING BETWEEN COMMUNICATION NETWORKS 有权
    通信网络之间的分组 - 节点分组

    公开(公告)号:US20080096584A1

    公开(公告)日:2008-04-24

    申请号:US11862242

    申请日:2007-09-27

    IPC分类号: H04Q7/20

    CPC分类号: H04W68/12

    摘要: A system and method is disclosed to provide inter-packet-node paging between communication networks. The networks recognize whether inter-network paging is supported therebetween and advertise overlapping codes between networks having adjacent location areas. When the mobile station moves from the first network to the second network, the first network determines whether the second network shares an overlapping code therewith. If the networks share an overlapping code, the first network sends a paging request to the second network including link configuration information and the notification for the mobile station, wherein the notification can be delivered to mobile station in the second location area of the second communication network without the mobile station having to register in the second communication network.

    摘要翻译: 公开了一种提供通信网络之间的分组间节点寻呼的系统和方法。 网络识别是否在其间支持网络间寻呼,并在具有相邻位置区域的网络之间通告重叠的代码。 当移动站从第一网络移动到第二网络时,第一网络确定第二网络是否与其共享重叠的代码。 如果网络共享重叠代码,则第一网络向第二网络发送包括链路配置信息和移动台通知的寻呼请求,其中该通知可以被传送到第二通信网络的第二位置区域中的移动站 没有移动台必须在第二通信网络中注册。

    Double-Ended Pressure Contacting Electrical Terminal
    25.
    发明申请
    Double-Ended Pressure Contacting Electrical Terminal 失效
    双端接触电气端子

    公开(公告)号:US20080003888A1

    公开(公告)日:2008-01-03

    申请号:US10579370

    申请日:2004-11-19

    申请人: Xiang Xu

    发明人: Xiang Xu

    IPC分类号: H01R13/24

    CPC分类号: H01R13/2421 H01R2201/02

    摘要: An electrical terminal (30) includes first (34) and second (36) contact members having outer pressure contacting end portions (34a, 36a) for pressure engaging first and second electrical devices, respectively, along with enlarged inner end portions (34b, 36b). The pressure contacting end portion of one contact member is longer than the pressure contacting end portion of the other contact member. A sleeve (32) is provided with a through hole (44) for slidably receiving the inner end portions of the first and second contact members. The through hole has opposite open ends (44a, 44b) through which the pressure contacting end portions of the contact members project. A biasing member (38) is disposed in the through hole to resiliently bias the contact members in opposite directions.

    摘要翻译: 电端子(30)包括第一(34)和第二(36)接触构件,其具有用于分别与第一和第二电气装置分别压配合的外压接触端部(34a,36a)以及扩大的内端部分 b,36b)。 一个接触构件的压力接触端部比另一个接触构件的压力接触端部长。 套筒(32)设置有用于可滑动地容纳第一和第二接触构件的内端部分的通孔(44)。 通孔具有相对的开口端(44a,44b),接触构件的压力接触端部通过该端部突出。 偏置构件(38)设置在通孔中以使接触构件沿相反方向弹性偏置。

    Tankyrase H, compositions involved in the cell cycle and methods of use
    26.
    发明授权
    Tankyrase H, compositions involved in the cell cycle and methods of use 失效
    催乳素酶H,参与细胞周期的组合和使用方法

    公开(公告)号:US06887675B1

    公开(公告)日:2005-05-03

    申请号:US09843159

    申请日:2001-04-25

    摘要: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.

    摘要翻译: 本发明涉及对细胞周期有影响或与细胞周期有关的新型多肽,核酸和相关分子。 本文还提供了包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。 本发明还提供了鉴定介导细胞周期生物活性的新组合物的方法,以及这些组合物在疾病诊断和治疗中的应用。

    Methods of screening for modulation of cell cycle
    27.
    发明授权
    Methods of screening for modulation of cell cycle 有权
    筛选调节细胞周期蛋白PP5与RAD9结合的方法

    公开(公告)号:US06660511B1

    公开(公告)日:2003-12-09

    申请号:US09517779

    申请日:2000-03-03

    申请人: Ying Luo Xiang Xu

    发明人: Ying Luo Xiang Xu

    IPC分类号: C12N916

    摘要: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.

    摘要翻译: 本发明涉及对细胞周期有影响或与细胞周期有关的新型多肽,核酸和相关分子。 本文还提供了包含那些核酸序列的载体和宿主细胞,包含与异源多肽序列融合的本发明的多肽的嵌合多肽分子,与本发明的多肽结合的抗体以及本发明的多肽的制备方法 发明。 本发明还提供了鉴定介导细胞周期生物活性的新型组合物的方法,以及这些组合物在疾病诊断和治疗中的应用。

    Carboxamide compounds and methods for using the same
    28.
    发明授权
    Carboxamide compounds and methods for using the same 有权
    羧甲酰胺化合物及其使用方法

    公开(公告)号:US08362235B2

    公开(公告)日:2013-01-29

    申请号:US12695861

    申请日:2010-01-28

    CPC分类号: C07D401/12 C07D401/14

    摘要: Disclosed are carboxamide compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure in which R1, R2, R3, R4, T, p, q, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.

    摘要翻译: 公开了羧酰胺化合物以及药物组合物和使用方法。 一个实施方案是具有其中R 1,R 2,R 3,R 4,T,p,q,w和x如本文所述的结构的化合物。 在某些实施方案中,本文公开的化合物激活AMPK途径,并且可用于治疗与代谢有关的病症和病症。